Skip to main content

Table 1 Composition of bosutinib-HDL NPs and HDL NPs

From: Bosutinib high density lipoprotein nanoformulation has potent tumour radiosensitisation effects

 

Bosutinib (%)

Peptide (%)

Lipid (%)

Bosutinib-HDL NPs

11.4 ± 1.7

76.2 ± 8.8

12.3 ± 9.6

HDL NPs

–

33.5 ± 8.3

66.2 ± 8.8

  1. Data is reported as w/w %
Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us